Terms: = Kidney tumors AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Treatment
9 results:
1. Loss of heterozygosity of key tumor suppressor genes in advanced renal cancer patients treated with nivolumab.
Bersanelli M; Gnetti L; Azzoni C; Bottarelli L; Sverzellati N; Campanini N; Varotti E; Corrado M; Parziale R; Rapacchi E; Caruso G; Leonardi F; Silini EM; Buti S
Immunotherapy; 2018 Jul; 10(9):743-752. PubMed ID: 30008256
[TBL] [Abstract] [Full Text] [Related]
2. Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer.
Skrypkina I; Tsyba L; Onyshchenko K; Morderer D; Kashparova O; Nikolaienko O; Panasenko G; Vozianov S; Romanenko A; Rynditch A
Dis Markers; 2016; 2016():3693096. PubMed ID: 27725787
[TBL] [Abstract] [Full Text] [Related]
3. Exome-wide single-base substitutions in tissues and derived cell lines of the constitutive fhit knockout mouse.
Paisie CA; Schrock MS; Karras JR; Zhang J; Miuma S; Ouda IM; Waters CE; Saldivar JC; Druck T; Huebner K
Cancer Sci; 2016 Apr; 107(4):528-35. PubMed ID: 26782170
[TBL] [Abstract] [Full Text] [Related]
4. fhit-deficient normal and cancer cells are mitomycin C and UVC resistant.
Ottey M; Han SY; Druck T; Barnoski BL; McCorkell KA; Croce CM; Raventos-Suarez C; Fairchild CR; Wang Y; Huebner K
Br J Cancer; 2004 Nov; 91(9):1669-77. PubMed ID: 15494723
[TBL] [Abstract] [Full Text] [Related]
5. fhit: from gene discovery to cancer treatment and prevention.
Pekarsky Y; Zanesi N; Palamarchuk A; Huebner K; Croce CM
Lancet Oncol; 2002 Dec; 3(12):748-54. PubMed ID: 12473516
[TBL] [Abstract] [Full Text] [Related]
6. Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies.
Ishii H; Dumon KR; Vecchione A; Fong LY; Baffa R; Huebner K; Croce CM
JAMA; 2001 Nov; 286(19):2441-9. PubMed ID: 11712940
[TBL] [Abstract] [Full Text] [Related]
7. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis.
Dreijerink K; Braga E; Kuzmin I; Geil L; Duh FM; Angeloni D; Zbar B; Lerman MI; Stanbridge EJ; Minna JD; Protopopov A; Li J; Kashuba V; Klein G; Zabarovsky ER
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7504-9. PubMed ID: 11390984
[TBL] [Abstract] [Full Text] [Related]
8. Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both fra3b and the t(3;8) associated with hereditary renal cell carcinoma.
Wilke CM; Guo SW; Hall BK; Boldog F; Gemmill RM; Chandrasekharappa SC; Barcroft CL; Drabkin HA; Glover TW
Genomics; 1994 Jul; 22(2):319-26. PubMed ID: 7806217
[TBL] [Abstract] [Full Text] [Related]
9. Translocation t(3;8)(p14.2;q24.1) in renal cell carcinoma affects expression of the common fragile site at 3p14(fra3b) in lymphocytes.
Glover TW; Coyle-Morris JF; Li FP; Brown RS; Berger CS; Gemmill RM; Hecht F
Cancer Genet Cytogenet; 1988 Mar; 31(1):69-73. PubMed ID: 3125959
[TBL] [Abstract] [Full Text] [Related]
